Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 261 composition records across product categories including Laboratory supplies, Food and drug, Cleaning products and household care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of TRISODIUM CITRATE DIHYDRATE in our catalog (epa_cpdat).
Products
261
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 261 composition records across product categories including Laboratory supplies, Food and drug, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Chelating agent, pH regulating agent, Preservative.
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 25 mg
US
FDA
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: INTRACARDIAC; Dosage form: INJECTION; Maximum daily exposure: 21 mg
US
FDA
Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 0.03 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 3480 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1188 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: 0.03 %w/v
US
FDA
Route: INTRAOCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 5.48 mg/1ml
US
FDA
Route: INTRAOCULAR; Dosage form: SOLUTION; Maximum daily exposure: 27 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 3480 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 800 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1188 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 41 mg
US
FDA
Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: 0.17 %w/v
US
FDA
Route: IRRIGATION; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 0.55 %w/v
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 9 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.45 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 7 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 35 mg
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 104 mg
US
FDA
Route: ORAL; Dosage form: ELIXIR; Maximum daily exposure: 68 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 4950 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 5010 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1200 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 5013 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 9 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 705 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 896 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 14 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 640 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 200 mg
US
FDA
Route: RECTAL; Dosage form: SOLUTION; Maximum daily exposure: 773 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Maximum daily exposure: 17 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Maximum daily exposure: 24 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Maximum daily exposure: 2 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 75 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 28 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 7 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 51 mg
US
FDA
Route: TOPICAL; Dosage form: CLOTH; Maximum daily exposure: 2 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 2 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 328 mg
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Maximum daily exposure: 186 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 186 mg
US
FDA
FDA NDC lists this ingredient in 45 active drug products and 45 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.